JAMA Network
What The Study Did: In this systematic review and meta-analysis of 22 studies, the risk of immediate allergic reactions and severe immediate reactions or anaphylaxis associated with a second dose of a SARS-CoV-2 mRNA vaccine was low among 1,366 patients who experienced an immediate allergic reaction to their first dose.
Authors: Matthew Greenhawt, M.D., M.B.A., M.Sc., of the University of Colorado School of Medicine in Aurora, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2021.8515)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
